Skip to main content
Susan Buchbinder, MD, Internal Medicine, San Francisco, CA, Zuckerberg San Francisco General Hospital and Trauma Center

SusanPamelaBuchbinderMD

Internal Medicine San Francisco, CA

Physician

Dr. Buchbinder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Buchbinder's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1985 - 1988
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2025
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults  
    Michael S Saag, Melanie A Thompson, Constance A Benson, Susan P Buchbinder, Joseph J Eron, Donna M Jacobsen, JAMA

Press Mentions

  • HIV Vaccine Research Update with Dr. Dieffenbach from CROI 2023
    HIV Vaccine Research Update with Dr. Dieffenbach from CROI 2023February 22nd, 2023
  • Why Inventing a Vaccine for AIDS Is Tougher Than for COVID
    Why Inventing a Vaccine for AIDS Is Tougher Than for COVIDJanuary 26th, 2023
  • A Promising HIV Vaccine Just Failed an Important Clinical Trial
    A Promising HIV Vaccine Just Failed an Important Clinical TrialJanuary 20th, 2023
  • Join now to see all

Grant Support

  • Prevention Umbrella For MSM In The AmericasNational Institute Of Allergy And Infectious Diseases2009–2012
  • SAN Francisco Vaccine And Prevention UnitNational Institute Of Allergy And Infectious Diseases2007–2012
  • SAN Francisco HIV Vaccine Clinical Trails UnitNational Institute Of Allergy And Infectious Diseases2000–2006
  • Phase II Extended Safety Study Of Tenofovir Disoproxil Fumarate (TDF) Among HNational Center For Research Resources2005
  • HVTN Protocol 056, Version 1: A Phase I Clinical Trial To Evaluate The Safety AnNational Center For Research Resources2005
  • HVTN Protocol 042/Anrs Vac019, Version 1: A Phase I/II Clinical TrialNational Center For Research Resources2005
  • HVTN 057: A Phase I Clinical Trial To Evaluate The Safety Of A Multiclade RECNational Center For Research Resources2005
  • HVTN 052: HIV-1 DNA Plasmid Vaccine At 2 Different Dosings In Hiv-1-Uninfected ANational Center For Research Resources2005
  • HVTN 050/Merck 018safety, Tolerability, And Immunogenicity Of Mrkad5 HIV-1 GAG VNational Center For Research Resources2005
  • Safety, Tolerability, And Immunogenicity Of Mrkad5 HIV-1 GAG VaccineNational Center For Research Resources2004
  • HIV-1 Pga2/Js2 Plasmid DNA Vaccine In HIV-1 Uninfected AdultsNational Center For Research Resources2004
  • HIV-1 DNA Plasmid Vaccine At 2 Different Dosings In Hiv-1-Uninfected AdultsNational Center For Research Resources2004
  • Trial Of Live (PRIVATE) Recombinant Canarypox Alva-Hiv Vcp205 In HIVNational Center For Research Resources1998–2000

Hospital Affiliations